Plasmid-encoded fusidic acid resistance in Escherichia coli is mediated by a common variant of chloramphenicol acetyltransferase (EC 2.3.1.28), an enzyme which is an effector of chloramphenicol resistance. Resistance to chloramphenicol is a consequence of acetylation of the antibiotic catalysed by the enzyme and the failure of the 3-acetoxy product to bind to bacterial ribosomes. Cell-free coupled transcription and translation studies are in agreement with genetic studies which indicated that the entire structural gene for the type I chloramphenicol acetyltransferase is necessary for the fusidic acid resistance phenotype. The mechanism of resistance does not involve covalent modification of the antibiotic. The other naturally occurring enterobacterial chloramphenicol acetyltransferase variants (types II and III) do not cause fusidic acid resistance. Steady-state kinetic studies with, the type I enzyme have shown that the binding of fusidic acid is competitive with respect to chloramphenicol. The inhibition of polypeptide chain elongation in vitro which is observed in the presence of fusidic acid is relieved by addition of purified chloramphenicol acetyltransferase, and equilibrium dialysis experiments with [3Hlfusidate and the type I enzyme have defined the stoichiometry and apparent affinity of fusidate for the type I enzyme. Further binding studies with fusidate analogues, including bile salts, have shown some of the structural constraints on the steroidal skeleton of the ligand which are necessary for binding to the enzyme. Determinations of antibiotic resistance levels and estimates of intracellular chloramphenicol acetyltransferase concentrations in vivo support the data from experiments in vitro to give a coherent mnechanism for fusidic acid resistance based on reversible binding of the antibiotic to the enzyme. 
polypeptide chain elongation in vitro which is observed in the presence of fusidic acid is relieved by addition of purified chloramphenicol acetyltransferase, and equilibrium dialysis experiments with [3Hlfusidate and the type I enzyme have defined the stoichiometry and apparent affinity of fusidate for the type I enzyme. Further binding studies with fusidate analogues, including bile salts, have shown some of the structural constraints on the steroidal skeleton of the ligand which are necessary for binding to the enzyme. Determinations of antibiotic resistance levels and estimates of intracellular chloramphenicol acetyltransferase concentrations in vivo support the data from experiments in vitro to give a coherent mnechanism for fusidic acid resistance based on reversible binding of the antibiotic to the enzyme.
Fusidic acid is one of a small group of antibiotics which have a steroidal structure. It inhibits polypeptide chain elongation in prokaryotes by stabilizing the intermediary complex of ribosome with elongation factor G and GDP, thus preventing further rounds of GTP hydrolysis and concomitant elongation of the nascent polypeptide chain Abbreviations used: CAT, chloramphenicol acetyltransferase; CATI, CATI, CATIII, the three naturally occurring enterobacterial enzyme variants; cat, gene for CAT; Amp, ampicillin; Tet, tetracycline; Cml, chloramphenicol; Fus, fusidic acid; Kan, kanamycin; Nal, nalidixic acid (all used for antibiotic resistances).
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t To whom reprint requests should be addressed. Vol. 215 (reviewed by Cundliffe, 1981) . Chloramphenicol inhibits elongation but at the preceding peptidyl transfer step. Its structure differs in a number of respects from that of fusidic acid. Most genera of Gram-negative bacteria are intrinsically tolerant to concentrations of fusidic acid that inhibit Gram-positive bacteria (von Daehne et al., 1979) . Thus, to observe the phenotype of plasmid-borne fusidic acid resistance in Escherichia coli, it is necessary to use a fusidate-sensitive mutant strain as the plasmid host. Datta et al. (1974) used the fusidate-sensitive host strain DB 10 in the first reported study. Among 22 naturally occurring R-plasmids examined, seven conferred fusidic acid resistance. Six of these plasmids also encoded chloramphenicol resistance, including five which have been shown to specify the type I variant of chloramphemicol acetyltransferase, CAT, (Foster & Shaw, 1973; A. Bennett, unpublished work) .
Genetic mapping studies have been performed on two closely related R-plasmids (Mickel et al., 1977) each of which confer both the fusidic acid and chloramphenicol resistance phenotypes. Both deletion mapping (Dempsey & Willetts, 1976) and restriction endonuclease analysis (Lane & Chandler, 1977; Miki et al., 1978; Timmis et al., 1978) indicated that the chloramphenicol and fusidic acid resistance determinants were closely linked. Both resistance markers were shown subsequently to be present on transposons related to Tn9 (Arber et al., 1978) . DNA sequence analysis of Tn9 (Alton & Vapnek, 1979) , Tn981 (Marcoli et al., 1980) and plasmid pBR325 (Prentki et al., 1981) demonstrated that a 906 base-pair sequence is sufficient to promote and code for both fusidic acid and chloramphenicol resistance. The only translational reading frame in this nucleotide sequence capable of encoding a polypeptide of more than 65 amino acid residues is that which specifies a protein identical in amino acid sequence to the CATI variant studied by Shaw et al. (1979) . Volker et al. (1982) have demonstrated that amber mutations in plasmid pBR325 near the beginning and end of the structural gene for CATI result in the loss of resistance to both chloramphenicol and fusidic acid. Informational suppression by appropriate suppressor tRNA molecules restores both resistance phenotypes. In addition, mutants of CATI which are temperaturesensitive for chloramphenicol resistance are also temperature-sensitive for fusidic acid resistance and simultaneous reversion to temperature-independent resistance is observed. It would appear, therefore, that despite the structural dissimilarity of the two antibiotics, the resistance phenotype in each case is due to the same gene product. This report summarizes the results of experiments with the CAT system which provide functional data that is in agreement with the conclusions of the genetic studies. (1975) . The non-radioactive compounds above were used as the sodium salts when supplied; free acids were converted to their corresponding sodium salts by mild treatment with NaOH (Carey et al., 1975 (Datta et al., 1974) . This strain was used as the sensitive host to score the fusidic acid resistance phenotype conferred by the plasmids used in this study. Plasmid-containing strains generally exhibited reduced resistance to sodium nalidixate as previously observed (Werner & Daneck, 1981) . E. coli C600: lacYI,leuB6,thil,supE44,tonA21 (reviewed by Bachman, 1972) . This strain was used to observe the phenotype of normal fusidate-tolerant E. coli on antibiotic-containing agar plates. In addition, because growth rates, plasmid yields, and CAT yields were greater for plasmid-containing C600 strains than when DB10 contained the same plasmids, it was used as the host when purifying CAT enzymes and plasmid DNA.
Materials and methods
Plasmids. The plasmids used were as listed in Table 1 . Plasmid DNA was transformed into the host strains using the procedure of Kushner (1978) . Bacterial growth media L broth contained (per litre): lOg of tryptone, 5 g of yeast extract, 5 g of NaCl and 1 g of D-glucose. 2YT broth contained (per litre): 16 g of tryptone, lOg of yeast extract and 5g of NaCl; 2YT agar contained the same plus 1.5% (w/v) agar. M56/ CAT medium was 56/2 minimal medium (Willetts et al., 1969) (10,ug/ml) depending on the plasmid being studied. Plasmid DNA was amplified by addition of 170,ug of chloraniplienicol/ml (Clewell, 1972) or, in instances where the plasmid specified chloramphenicol resistance, spectinomycin at a concentration of 300,ug/ml (Bolivar, 1978) .
Determination ofantibiotic-resistance levels Resistance levels were estimated by the gradient plate method (Meynell & Meynell, 1970 ) using 50ml of 2YT agar containing an appropriate concentration of antibiotic and set in a wedge in the bottom of a square Petri dish (10 cm x 10 cm). The Petri dish was then returned to the horizontal and the same volume of antibiotic-free 2YT agar was poured in to form an upper wedge. After 1 h when the agar was set and its surface had been dried, bacteria growing exponentially in 2YT broth (A660 0.4) were applied.
The application was performed by dipping 0.5cm wide strips of sterile Whatman 3MM paper into the bacterial suspension, allowing them to drain until free of excess culture medium, and then laying these momentarily across the surface of the agar. The strips were applied in parallel lines up the concentration gradient which was formed by diffusion of the antibiotic out of the lower wedge. Antibiotic resistance was scored after 16h incubation at 370C by distance of visible growth across the surface of the agar.
Protocolfor investigation ofantibiotic inactivation
Eight conical flasks (250ml) containing 40ml of 2YT broth were prepared with and without a sub-inhibitory concentration of sodium fusidate
(1 pg/ml). Each was inoculated with single colonies of strains of DB10 and C600 carrying no plasmid, pBR328, pKT205 or pAH1, the plasmids specifying respectively the type I, type II, and type III variants of CAT (see Table 1 ).
After the flasks had been shaken for 12h at 370C, sodium fusidate was added to a final concentration of 40,pg/ml. After a further 3 h of shaking, the total lipids of the culture were extracted by the method of Bligh & Dyer (1959) show as red, yellow or brown spots). The sensitivity of this method is such that it can be expected to discern as little as 0.5% modification of the antibiotic.
Transcription and translation studies
Coupled transcription and translation studies in vitro were carried out using the method and cell extracts described by Pratt et al. (1981) with 5 pg of plasmid DNA per incubation. Mr standards (Sigma MW-SDS-70) were identified by Coomassie Blue stain (Packman & Shaw, 1981) and marked with radioactive ink prior to autoradiography.
Chloramphenicol acetyltransferase purification
The three enzyme variants, CATI, CATII and CAT,,,, were purified to homogeneity from separate strains of C600 carrying the plasmids pBR328, pKT205 and pAH 1 respectively. Plasmid pBR328 was used in preference to plasmid pBR325 since it has the same gene for CATI and because its copy number is elevated (Covarrubias et al., 1981) , thus providing a significant increase in enzyme yield. Cells were grown in 1-3 litres of M56/CAT medium and harvested in the exponential phase of growth. M56/CAT medium was used because expression of the gene for CAT, is sensitive to catabolite repression (Le Grice et al., 1982) and CAT, yields in the absence of glucose or other repressing carbon sources are at least double those obtained in complex media.
Purification of CATI and CATIII was by the procedure of Packman & Shaw (1981) with the following modifications. (a) The use of phenylmethanesulphonyl fluoride and deoxyribonuclease was omitted. (b) EDTA (0.1mM) was included in the 'standard buffer' (50mM-Tris/HCl, pH 7.8, containing 0.1 mM-2-mercaptoethanol) throughout.
(c) CATI was eluted from the low substitution affinity resin with standard buffer containing 0.3M-NaCl and 5mM-chloramphenicol. (d) CATIII was eluted from the high substitution affinity resin with standard buffer containing 0.6M-NaCl and 5mM-chloroamphenicol. CATII was purified without the 10min heat step because of its heat lability, but the procedure employed the same affinity resin as that used for the CATIII enzyme but with the low salt wash and elution buffers of the CAT, purification as outlined above. The specific activity of purified CATII from strain C600 carrying plasmid pKT205 was approx. 600units/mg of protein.
Chloramphenicol acetyltransferase activity was assayed by the spectrophotometric method of Shaw (1975) . One unit is defined as the amount of enzyme which catalyses the production of 1,umol of product/min at 370C. (1974) and was a gift from Dr. E. Cundliffe. Ribosomes were prepared by a modification of the method of Cundliffe et al. (1979) .
The reaction mixture (final volume 75ul) contained 15mM-Tris/HCl, pH7.8, lOmM MgSO4, 80 mM-NH4Cl, 2 mM-2-mercaptoethanol, 10nmol of [y-32PIGTP (approx. 1.5 x 106 c.p.m.) and 50pmol of elongation factor G. This was pre-warmed to 370C for 10min and the reaction was started by the addition of 1 pmol (10,ul) of ribosome solution.
Sodium fusidate and purified CAT were included when required before addition of the ribosome solution. Three 20,1 samples were taken from each reaction after incubation at 370C for 20min and were each mixed with 20,ul of ice-cold 1 M-HC104 in a 1.5 ml Eppendorf tube. After 10min on ice, 200,l of 5% (w/v) activated charcoal (prepared by the method of Thompson, 1960) was added and each tube was mixed by agitation on a vortex mixer for 30s to adsorb free ribonucleotides. After centrifugation for 3 min in an Eppendorf microcentrifuge, 100,l of the supernatant containing the hydrolysed radioactive inorganic phosphate was removed for scintillation counting. A control incubation lacking elongation factor G was included to estimate the extent of background ribosome-independent GTP hydrolysis.
Equilibrium dialysis
Equilibrium dialysis was performed at 40C in two separate eight-place dialysis modules (Hoefer Scientific Instruments, San Francisco, CA, U.S.A.). Each cell in the apparatus is divided into two 0.5 ml chambers by a dialysis membrane with a 12000-14 000 Mr cut-off. On one side of the membrane was a fixed concentration of each CAT variant (Mr approx. 100000) in 5OmM-Tris/HCl (pH 7.8)/ 0.1 mM-2-mercaptoethanol/0.1 mM-EDTA. The opposite side of the cell contained a variable concentration (0-125,uM) of the diethanolamine salt of [3Hlfusidic acid in the same buffer. Two control places were reserved in each experiment to check (a) that equilibrium had been achieved and (b) the activity of CAT after dialysis. The modules were rotated at I0rev./min for 90h to allow equilibrium to be achieved for the highest concentration of fusidate. After dialysis five duplicate samples of 50,1 were withdrawn from both sides of each pair of chambers and counted in 4 ml of Bray's fluid (Fox, 1976) . The mean values of the fusidate present in each chamber was determined and the results were plotted according to Scatchard (1949) . A regression line then was fitted to each set of 14 points. The binding strengths of non-radioactive analogues competing with the [3Hlfusidate were calculated by using the equation of Edsall & Wyman (1958) .
Results

Antibiotic resistance levels
Plasmids which carry the gene for CAT, confer resistance to fusidate which can be detected in fusidate-sensitive hosts such as DB10. There is no change in the fusidate-sensitivity phenotype for DB 10 derivatives harbouring homologous plasmids which lack the gene for CATI. This includes plasmids with amber mutations in the CATI gene and those which carry the genes for CATII and CAT,,, (Table 1 ). The latter observations are noteworthy in view of the many close similarities which exist among the three enterobacterial CAT proteins (Gaffney et al., 1978; Zaidenzaig et al., 1979 , and reviewed by Shaw, 1983 (Sutcliffe, 1979) as template DNA. The polypeptides of apparent Mr 30000, 28000 and 25000 correspond to the three polypeptides related to f-lactamase which were identified immunologically by Dougan et al. (1979) in pBR322-containing minicells. Protein bands of apparent Mr 34000 and 18000 which have been reported to be associated with the constitutive (Kahn et al., 1978; Grinter, 1978) . 11 pAB02 was constructed by insertion of a PstI restriction fragment from the R plasmid EDR51 into the PstI site of the fl-lactamase gene of pNJ2004. EDR5 1 is a deletion derivative of R100 constructed by Dempsey & Willetts (1976) . (Shaw, 1975 
Relief of inhibition ofpolypeptide chain elongation in vitro
The rate of polypeptide chain elongation in vitro was monitored on the basis of the rate of ribosomedependent GTP hydrolysis. The latter occurs in the absence of both exogenous mRNA and amino-acyl tRNA molecules but is dependent on the presence of elongation factor G. Maximal rates of GTP hydrolysis under the conditions described were observed only when fusidate was absent. The mean value of maximal GTP hydrolysis was 101 pmol/min during the 20min incubation. At a final fusidate concentration of 1.OpM (0.54,ug/ml), ribosome-dependent GTP hydrolysis is 55% of the maximal rate, an observation in close agreement with the findings of Okura et al. 1970 Scatchard (1949) (Fig. 2) . The equilibrium dissociation constant, Kd, calculated from the data was 25.2pM, and the value of the intercept on the abscissa (1.06) implies an equimolar binding ratio between CAT1 monomers and fusidate. In addition, the slope of the plot was linear, merely to the general hydrophobicity of the antibiotic or be a consequence of more specific interactions. Such experiments were performed as described above, but in each case a non-radioactive analogue of fusidate was included at a fixed concentration. The dissociation constants of the competing analogues were calculated from the resulting data using the equation of Edsall & Wyman (1958) [11, type I variant of chloramphenicol acetyltr equilibrium dialysis The experiments were performed as descr Materials and methods section and wer according to Scatchard (1949 Table 2 ). rielded the Seven fusidate analogues were used in separate -d in Table   competition experiments (Fig. 3) Fig. 4 . Bile salts used in this study to fusidate, a study was made of the binding properties of some steroidal bile salts (Fig. 4) . Such experiments were prompted by observations of Proctor & Rownd (1982) which pointed to an interaction of bile salts with CAT,.
Fusidate analogues and bile salts were also tested for antibiotic activity against strain DB1O and a number of plasmid-bearing derivatives. The data in Table 2 summarize the results of such experiments as well as the data from competition equilibrium dialysis studies (Fig. 2) . As The absence of any chromatographically detectable change in the fusidate molecule after incubation with CATI-containing E. coli is in keeping with the findings of bioassay studies performed by Werner & Daneck (1981) and by S. Scannell & W. V. Shaw (unpublished work). Both groups failed to demonstrate a decrease in the level of antistaphylococcal growth inhibition caused by preexposure to fusidate of E. coli DB10 strains which contained plasmids conferring fusidate resistance. Werner & Daneck (1981) postulated that DB10 was fusidate-sensitive because of reduced levels of cyclopropane fatty acids and phosphatidylethanolamine. They speculated that plasmid-borne fusidate resistance might be due to an alteration in the synthesis of such phospholipids which in turn was controlled by plasmid genes. However, the observation that DB10 is low in cyclopropane fatty acids may have no immediate or obvious relevance to fusidate sensitivity, since the E. coli mutants isolated by Taylor & Cronan (1976) are defective in cyclopropane fatty acid synthetase but are as resistant to fusidate as are wild type E. coli strains (results not shown).
Specificity of CA T, forfusidic acid
It has been reported that CATI fails to mediate resistance to the antibiotics helvolinic acid (6-deacetoxyhelvolic acid) and cephalosporin P1 (V6lker et al., 1982) . Although interesting, these observations fail to give a clear insight as to the nature of the specificity of CAT, for fusidane compounds, since both analogues differ from fusidic acid at several positions (Fig. 3) . The results of the competition equilibrium dialysis experiments described above on several fusidic acid analogues and bile salts (Fig. 4) show the CAT, binding specificity (Table 2) . In addition to position 3, the only site tested which fails to 'tolerate even a small change is position 7. Minor changes in the nature of the groups at positions 4, 5, 9, 11, 12, 13, 14 and 16 are accepted and major changes to the side chain at position 17 are also permitted.
A coherent mechanism for CA T,-mediated fusidate resistance in vivo
The experiments described represent an extension of the genetic proof offered by Volker et al. (1982) that the structural gene for CATI is required for both the chloramphenicol and fusidate resistance phenotypes. For the CATI enzyme to represent a plausible resistance mechanism based solely on reversible fusidate binding it ought to satisfy two criteria.
Firstly, the concentration of CATI within the cell must be sufficient to bind and sequester the incoming antibiotic and, secondly, the affinity of fusidate for the enzyme must approximate or exceed that of fusidate for the complex of ribosome GDP and elongation factor G. (The results indicate that there is a 1: 1 binding stoichiometry between each of the CAT, subunits and fusidate.)
The extent of increase in the observed fusidate resistance of DB10 strains carrying mini-plasmids over the plasmid-free host strain was determined on 2YT agar gradient plates (Table 1) . For DB10 carrying two of the plasmids specifying CAT, (pBR325 and pBR328) this increase is 75 and 100lg/ml respectively, corresponding to an increase in fusidate concentrations of 138 and 185,M. The specific activity of CAT, in crude extracts of DB10 carrying pBR325 and of DB10 with pBR328 was determined from cells grown in 2YT broth. Under such conditions CATI is present as 2.8% and 3.7% of the total intracellular protein respectively. If 15% of the wet weight of E. coli is presumed to be protein this would imply intracellular CATI monomer concentrations of 175 and 230,uM respectively.
The apparent affinity of CAT, for fusidate was determined in two ways which might reasonably be expected to yield similar values. Equilibrium dialysis gave a Kd value of approx. 30,UM whereas steadystate kinetics gave an apparent K; value 20-fold lower. Although both experiments were performed in nearly identical buffers, the steady-state kinetic experiments were performed in the presence of saturating levels of acetyl-CoA at 370C whereas the equilibrium dialysis in the absence of coenzyme took place at 40C. The latter conditions were dictated by the known ability of CAT, to hydrolyse acetyl-CoA slowly in the absence of chloramphenicol (Shaw, 1983) . If the observed K, value (1.7,M) is a more realistic reflection of the situation in vivo wherein acetyl-CoA is present, then it is worth noting that this value approaches that ofthe reported dissociation constants for interactions of the ribosome-GDPelongation factor G complex with fusidate (0.4 gm observed by Okura et al., 1971 ) and 24,25-dihydrofusidate (0.39 uM noted by Willie et al., 1975) .
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